Otsuka (OTCMKTS:OTSKY) Announces Earnings Results, Beats Estimates By $0.19 EPS

Otsuka (OTCMKTS:OTSKY) announced its quarterly earnings results on Friday. The company reported $0.70 earnings per share for the quarter, topping analysts’ consensus estimates of $0.51 by $0.19, Zacks reports. Otsuka had a return on equity of 12.33% and a net margin of 15.01%. Otsuka updated its FY 2026 guidance to 2.119-2.119 EPS.

Otsuka Stock Performance

Shares of OTSKY traded down $1.42 during mid-day trading on Friday, reaching $34.41. The company’s stock had a trading volume of 50,465 shares, compared to its average volume of 39,967. The company has a current ratio of 2.17, a quick ratio of 1.67 and a debt-to-equity ratio of 0.05. Otsuka has a 1-year low of $23.67 and a 1-year high of $37.52. The business has a 50-day simple moving average of $34.19 and a two-hundred day simple moving average of $33.51. The stock has a market cap of $36.96 billion and a P/E ratio of 14.52.

About Otsuka

Otsuka Pharmaceutical Co, Ltd., trading in the U.S. under the ticker OTCMKTS:OTSKY, is a global healthcare company headquartered in Tokyo, Japan. The firm’s core activities span the development, manufacturing and marketing of prescription pharmaceuticals, consumer healthcare products and nutraceuticals. Otsuka focuses its research on areas such as neuroscience, cardiovascular and renal therapies, and oncology, aiming to bring innovative treatments to patients worldwide.

Founded in 1964 by Busaburo Otsuka as a subsidiary of the Otsuka Group, the company has grown into a diversified healthcare enterprise over more than five decades.